14-day Premium Trial Subscription Sign Up For FreeGet Free

$7.07 (2.02%)

Volume: 1M

Closed: Dec 07, 2021

Hollow Logo Score: 3.978

Catalyst Pharmaceuticals Stock Forecast

$7.07 (2.02%)

Volume: 1M

Closed: Dec 07, 2021

Score Hollow Logo 3.978
Which way will CPRX go? Request
Stop-loss: $6.73 (-4.79%)
Key Stats
Beta 0.95
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
RSImin/max Values: [ 25 - 75 ] RSI14 is 46 and the stock is currently not being overbought or oversold

Green day on Tuesday for Catalyst Pharmaceuticals stock after gaining 2.02%
(Updated on Dec 07, 2021)

Buy or Hold candidate since 2021-10-04 Gain 32.65%

The Catalyst Pharmaceuticals stock price gained 2.02% on the last trading day (Tuesday, 7th Dec 2021), rising from $6.93 to $7.07. , and has now gained 3 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the day the stock fluctuated 5.92% from a day low at $6.76 to a day high of $7.16. The price has risen in 6 of the last 10 days, but is still down by -2.75% for this period. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 456 thousand more shares were traded than the day before. In total, 1 million shares were bought and sold for approximately $8.48 million.

The stock lies in the middle of a wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 47.88% during the next 3 months and, with a 90% probability hold a price between $10.10 and $11.81 at the end of this 3-month period.

Signals & Forecast

The Catalyst Pharmaceuticals stock holds buy signals from both short and long-term moving averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $6.96 and $6.64. A breakdown below any of these levels will issue sell signals. Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Wednesday, November 17, 2021, and so far it has fallen -5.10%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss

Catalyst Pharmaceuticals finds support from accumulated volume at $6.86 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.40 between high and low, or 5.92%. For the last week, the stock has had a daily average volatility of 4.78%.

Our recommended stop-loss: $6.73 (-4.79%) (This stock has medium daily movements and this gives medium risk. There is a sell signal from a pivot top found 13 days ago.)

Is Catalyst Pharmaceuticals stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Catalyst Pharmaceuticals stock to perform well in the short-term.

Current score: 3.978

Predicted Opening Price for Catalyst Pharmaceuticals of Wednesday, December 8, 2021

The predicted opening price is based on yesterday's movements between high, low, and the closing price.

Fair opening price December 8, 2021 Current price
$7.00 $7.07 (Overvalued)
Buy Candidate Unchanged

Remember To Visit Our YouTube Channel

Analyst Ratings

On Oct 01, 2021 "HC Wainwright" gave "$9.00" rating for CPRX. The price target was changed from $5.13 to 3.2%.

Volatility and Risk
Daily Average Volatility: 4.78 %
Overall Risk: Very High High Medium Low Very Low
4.78 %
Daily Average Volatility
Overall Risk

Very High
Very Low

Support & Resistance

Resistance: $7.30
Price: $7.07
Support: $6.86

CPRX Insider Trading Show all Trades



Last 100 transactions
Buy: 3 014 995 | Sell: 1 687 607 (Shares)
Date Action Amount Person Type
Dec 03, 2021 Sell 30 833 Mcenany Patrick J Restricted Stock Units
Dec 03, 2021 Sell 12 132 Mcenany Patrick J Common Stock, par value $0.001 per share
Dec 03, 2021 Buy 30 833 Mcenany Patrick J Common Stock, par value $0.001 per share
Dec 03, 2021 Buy 14 667 Grande Alicia Restricted Stock Units
Dec 03, 2021 Sell 3 571 Grande Alicia Common Stock, par value $0.001 per share
Show all Insider Trades


Last 100 transactions
Buy: 3 014 995 | Sell: 1 687 607 (Shares)

Fibonacci Support & Resistance Levels

Level Price Change
Resistance 7.40 4.62 %
7.24 2.46 %
7.15 1.12 %
Current price: 7.07
Support 6.84 -3.20 %
6.75 -4.53 %
6.60 -6.69 %

Accumulated Volume Support & Resistance Levels

Level Price Chg %
Resistance 7.41 4.81 %
7.32 3.54 %
7.30 3.25 %
Current price 7.07
Support 6.86 -2.97%
6.54 -7.50%
6.12 -13.44%

Click to get the best stock tips daily for free!

About Catalyst Pharmaceuticals

Catalyst Pharmaceuticals Catalyst Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies for people with rare debilitating diseases. Its lead product candidate is Firdapse, a proprietary form of amifampridine phosphate, which completed Phase III clinical trial for the treatment of patients with Lambert-Eaton Myasthenic syndrome; and is in small blinded clinical trial to treat Congenital Myasthenic syndromes, as w... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!

StockInvest.usJoin 100 000+ Happy Subscribers

Don't miss out on the runners!

Get The StockInvest.Us Newsletter

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE